These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12609781)

  • 1. The use of lymecycline in the treatment of moderate to severe acne vulgaris: a comparison of the efficacy and safety of two dosing regimens.
    Dubertret L; Alirezai M; Rostain G; Lahfa M; Forsea D; Niculae BD; Simola M; Horvath A; Mizzi F
    Eur J Dermatol; 2003; 13(1):44-8. PubMed ID: 12609781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the efficacy and safety of lymecycline and minocycline in patients with moderately severe acne vulgaris.
    Grosshans E; Belaïch S; Meynadier J; Alirezai M; Thomas L
    Eur J Dermatol; 1998; 8(3):161-6. PubMed ID: 9649660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
    Dréno B; Kaufmann R; Talarico S; Torres Lozada V; Rodríguez-Castellanos MA; Gómez-Flores M; De Maubeuge J; Berg M; Foley P; Sysa-Jedrzejowska A; Kerrouche N; Paliargues F; Bettoli V
    Br J Dermatol; 2011 Aug; 165(2):383-90. PubMed ID: 21495995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline.
    Alirezai M; George SA; Coutts I; Roseeuw DI; Hachem JP; Kerrouche N; Sidou F; Soto P
    Eur J Dermatol; 2007; 17(1):45-51. PubMed ID: 17324827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymecycline in the treatment of acne: an efficacious, safe and cost-effective alternative to minocycline.
    Bossuyt L; Bosschaert J; Richert B; Cromphaut P; Mitchell T; Al Abadie M; Henry I; Bewley A; Poyner T; Mann N; Czernielewski J
    Eur J Dermatol; 2003; 13(2):130-5. PubMed ID: 12695127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
    Leyden J; Thiboutot DM; Shalita AR; Webster G; Washenik K; Strober BE; Shupack J
    Arch Dermatol; 2006 May; 142(5):605-12. PubMed ID: 16702498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy comparison of minocycline microgranules vs lymecycline in the treatment of mild to moderate acne: randomized, evaluator-blinded, parallel, and prospective clinical trial for 8 weeks.
    Ocampo-Candiani J; Velazquez-Arenas LL; de la Fuente-Garcia A; Trevino-Gomezharper C; Berber A
    J Drugs Dermatol; 2014 Jun; 13(6):671-6. PubMed ID: 24918556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, randomized, placebo-controlled study of a lotion containing triethyl citrate and ethyl linoleate in the treatment of acne vulgaris.
    Charakida A; Charakida M; Chu AC
    Br J Dermatol; 2007 Sep; 157(3):569-74. PubMed ID: 17635508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris.
    Shalita AR; Myers JA; Krochmal L; Yaroshinsky A;
    J Drugs Dermatol; 2005; 4(1):48-56. PubMed ID: 15696985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
    McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized double-blind study to assess the effects of silicic acid compared to placebo in patients with mild to moderate acne.
    Fernandez C; Adamson K; Dale M; Cunliffe WJ
    J Dermatolog Treat; 2005; 16(5-6):287-94. PubMed ID: 16428147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.
    Palombo-Kinne E; Schellschmidt I; Schumacher U; Gräser T
    Contraception; 2009 Apr; 79(4):282-9. PubMed ID: 19272497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne.
    Skidmore R; Kovach R; Walker C; Thomas J; Bradshaw M; Leyden J; Powala C; Ashley R
    Arch Dermatol; 2003 Apr; 139(4):459-64. PubMed ID: 12707093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsed azithromycin treatment is as effective and safe as 2-week-longer daily doxycycline treatment of acne vulgaris: a randomized, double-blind, noninferiority study.
    Maleszka R; Turek-Urasinska K; Oremus M; Vukovic J; Barsic B
    Skinmed; 2011; 9(2):86-94. PubMed ID: 21548512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E; Dhawan S; Torok H; Kircik L
    Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris.
    Alirezaï M; Gerlach B; Horvath A; Forsea D; Briantais P; Guyomar M
    Eur J Dermatol; 2005; 15(4):274-8. PubMed ID: 16048758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.
    Draelos ZD; Carter E; Maloney JM; Elewski B; Poulin Y; Lynde C; Garrett S;
    J Am Acad Dermatol; 2007 Mar; 56(3):439.e1-10. PubMed ID: 17208334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.